Shreya launches new generation ''Viagra'' variant
By Our Corporate Bureau | 01 Apr 2004
Shreya Life Sciences has launched the new drug, Tadalafil, for the treatment of erectile dysfunction. The drug has been introduced in two strengths under the brand names TD 36 and TD 36 XP.
Tadalafil
is considered superior to Sildenafil citrate in the
widely-used Viagra, since it acts faster and its effect
lasts 36 hours. It has fewer side-effects and is approved
for use in over 30 countries including the US. Tadalafil
has been found safe for use by diabetes
and hypertension patients and has no interaction with
food or moderate alcohol. The drug is available only
on prescription of specialised doctors.